Jim Cramer's top 10 things to watch in the stock market Friday

Adobe said CFO Dan Durn is leaving to join Marvell, alongside earnings where the stock is down 7% and multiple downgrades were issued.

Near-term downside bias or elevated volatility until successor/trajectory clarity emerges.

The article ties the CFO exit to a post-earnings selloff and names specific downgrade sources, implying fresh negative sentiment rather than a purely historical recap.

Marvell is named as the destination for Adobe’s departing CFO Dan Durn, signaling a personnel-driven shift in software-to-semiconductor leadership.

Modest positive bias possible, mainly via sentiment/positioning rather than immediate fundamentals.

The article discloses the executive move but provides no direct Marvell guidance, deal terms, or financial impact.

AMD was upgraded to buy from hold at Citi, with Citi arguing AMD is a legitimate second GPU source and expecting Meta to buy more AMD chips.

Upside bias and potential multiple expansion if the market treats the Meta read-across as credible.

The article includes an explicit upgrade action and a named customer/volume thesis (Meta) that can drive near-term positioning.

Nokia’s price target was raised by JPMorgan to $21 from $14, citing its AI networking reinvention and a Nvidia partnership.

Moderate upside bias, especially if investors focus on AI networking demand and partnership execution.

This is a specific, attributable PT change with a clear fundamental rationale (AI networking + Nvidia partnership).

Teradyne is listed as one of the Nasdaq 100 additions before June 22, implying index-tracking flows into AI infrastructure names.

Potential short-term inflow support around the effective date, with limited fundamental follow-through.

The only disclosed fact is index membership timing; without price/flow estimates, impact is uncertain.

Bank of America cut price targets across medical devices, including Medtronic, attributing weakness to P/E compression since the fall.

Near-term negative bias for MDT relative to peers if the market reprices the sector’s earnings outlook.

The article explicitly states PT cuts and the valuation-compression thesis for the group.

Bank of America cut price targets across medical devices, including Stryker, citing serious P/E compression.

Potential continued downside/relative weakness until guidance offsets the valuation reset.

The article provides a direct analyst action (PT cuts) and a sector-wide valuation rationale.

Bank of America cut price targets across medical devices, including Becton Dickinson, due to P/E compression.

Downside bias or choppy trading as investors digest reduced expectations.

This is a concrete PT-cut event with a stated valuation mechanism (P/E compression).